Biosceptre (Aust) Pty Ltd.
Records under this name other than the patents Biosceptre (Aust) Pty Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 23 patents it holds.
Showing 1 to 8 of 8 · Back to Biosceptre (Aust) Pty Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,326,415 | Antibodies to non-functional P2X7 receptor Term ended Term ended Apr 30, 2023 · From the USPTO record | Term ended | Term ended Apr 30, 2023 | From the USPTO record |
| US 7,531,171 | Antibodies to non-functional P2X7 receptor Term ended Ended no later than Jan 17, 2022 · From the USPTO record | Term ended | Ended no later than Jan 17, 2022 | From the USPTO record |
| US 8,080,635 | Non-functional P2X7 receptor Term ended Ended no later than Jan 17, 2022 · From the USPTO record | Term ended | Ended no later than Jan 17, 2022 | From the USPTO record |
| US 8,399,617 | Non-functional P2X7 receptor Term ended Ended no later than Jan 17, 2022 · From the USPTO record | Term ended | Ended no later than Jan 17, 2022 | From the USPTO record |
| US 8,709,425 | Antibodies to non-functional P2X7 receptor Term ended Ended no later than Jan 17, 2022 · From the USPTO record | Term ended | Ended no later than Jan 17, 2022 | From the USPTO record |
| US 9,663,584 | Antibodies to non-functional P2X7 receptor Term ended Ended no later than Jan 17, 2022 · From the USPTO record | Term ended | Ended no later than Jan 17, 2022 | From the USPTO record |
| US 10,450,380 | Polypeptide immunogen for generating an antibody to non-functional P2X7 receptor Term ended Ended no later than Jan 17, 2022 · From the USPTO record | Term ended | Ended no later than Jan 17, 2022 | From the USPTO record |
| US 7,183,064 | Method for identifying pre-neoplastic and/or neoplastic states in mammals Term ended Term ended Apr 26, 2020 · From the USPTO record | Term ended | Term ended Apr 26, 2020 | From the USPTO record |